LDLR and atherosclerosis: Pharmacological removal of senescent cells by ABT263 which inhibits anti-apoptotic proteins Bcl-2 and Bcl-x and selectively kills senescent cells [34] was also effective against atherosclerosis in Ldlr−/− mice [33].